Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
Within the Menarini Group, Berlin-Chemie is the regional headquarters for the CEE and CIS region and is responsible for more than 30 countries and their local subsidiaries.
As a reliable partner in the healthcare sector, we want to use our products and expertise to help solve the complex challenges in the healthcare sector in these regions. To this end, Berlin-Chemie has established strong partnerships at all levels in many countries. We support doctors and patients with high-quality medical products and technologies to improve the quality of life.
BERLIN-CHEMIE AG
Glienicker Weg 125
12489 Berlin, Deutschland
E-mail: info@berlin-chemie.de
Phone: +49 (0)30 6707-0
Fax: +49 (0)30 6707-2120
Since January 1, 2024, Berlin-Chemie AG has been the only Menarini Group company directly subject to the LkSG, as it had more than 1,000 employees as of December 31, 2023. Consequently, Berlin-Chemie AG is responsible for implementing the due diligence obligations for its subsidiaries and branches.
For more information see Berlin-Chemie AG Policy Statement.
The role of the Human Rights Officer, officially appointed by the Board of Director, is embedded in a company-wide governance structure. The governance structure takes into account the shared responsibility of all persons acting on behalf of the company to respect human rights.
In order to ensure compliance with human rights and environmental due diligence obligations, Berlin-Chemie AG set up a risk management system based on the “Line of defense model”.
Ethical and legally compliant behavior is a top priority for Berlin-Chemie AG, in terms of its own business activities and in its relationships with business partners and customers.
Berlin-Chemie AG employees and external stakeholders can anonymously report suspicions free of charge in various languages using this group-wide complaint system.
Further details on Berlin-Chemie AG complaints procedure and other channels can be found in the Rules of Procedure.